2 completed, 1 terminated. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow flupirtine: new trials by email Literature Review of flupirtine trials Research Report on flupirtine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peripheral KV7 Activation for Pain Relief Capsaicin only (7.6 ng), Capsaicin + Flupirtine 0.5 µg, Capsaicin + Flupirtine 1.2 µg - Pain | Early Phase 1 | Completed | Stefan Heber | 32 | 2025-05-08 | 2025-06-10 |
| Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo flupirtine - Axonal Change, Neuronal, Pain | Phase 1 | Completed | Ludwig-Maximilians - University of Munich | 20 | 2009-10-01 | 2015-01-13 |
| Flupirtine as Oral Treatment in Multiple Sclerosis Flupirtine, Placebo - Relapsing Remitting Multiple Sclerosis | Phase 2 | Terminated | Charite University, Berlin, Germany | 30 | 2007-12-01 | 2018-03-20 |
Pain (2) · Multiple Sclerosis, Relapsing-Remitting (1)
Charite University, Berlin, Germany (1) · Ludwig-Maximilians - University of Munich (1) · Stefan Heber (1)
Germany (2) · Austria (1)
Dominik Irnich, MD, PhD (1) · Friedemann Paul, MD (1)